Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha

Molecular Cancer Therapeutics
Mei Y KohGarth Powis

Abstract

We have reported previously that PX-478 (S-2-amino-3-[4'-N,N,-bis(chloroethyl)amino]phenyl propionic acid N-oxide dihydrochloride) has potent antitumor activity against a variety of human tumor xenografts associated with the levels of the hypoxia-inducible factor-1alpha (HIF-1alpha) within the tumor. We now report that PX-478 inhibits HIF-1alpha protein levels and transactivation in a variety of cancer cell lines. Hypoxia-induced vascular endothelial growth factor formation was inhibited by PX-478, whereas baseline levels of vascular endothelial growth factor in normoxia were unaffected. Studies of the mechanism of PX-478 action showed that HIF-1alpha inhibition occurs in both normoxia and hypoxia and does not require pVHL or p53. In addition, PX-478 decreases levels of HIF-1alpha mRNA and inhibits translation as determined by 35S labeling experiments and reporter assays using the 5' untranslated region of HIF-1alpha. Moreover, to a lesser extent, PX-478 also inhibits HIF-1alpha deubiquitination resulting in increased levels of polyubiquitinated HIF-1alpha. The inhibitory effect of PX-478 on HIF-1alpha levels is primarily due to its inhibition of translation because HIF-1alpha translation continues in hypoxia when translation o...Continue Reading

References

Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L E HuangH F Bunn
Apr 21, 2001·Molecular and Cellular Biology·T N SeagrovesR S Johnson
Jul 17, 2001·Cancer Genetics and Cytogenetics·O R SaramäkiT Visakorpi
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 27, 2002·Archives of Biochemistry and Biophysics·W David Strayhorn, Brian E Wadzinski
Jun 8, 2002·The Journal of Biological Chemistry·Jennifer S IsaacsLeonard M Neckers
Jul 9, 2002·Biochemical and Biophysical Research Communications·Feng WangKazuhiro Sogawa
Sep 21, 2002·Molecular and Cellular Biology·Christine C HudsonRobert T Abraham
Dec 20, 2002·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Peter VaupelMichael Höckel
May 3, 2003·Cancer Cell·Nicola J MabjeeshParaskevi Giannakakou
Jan 15, 2004·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Gottfried MartinHansjürgen T Agostini
Feb 7, 2004·Cancer Biology & Therapy·Gerald W HartNeeraja Sathyamoorthy
Apr 10, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Bradly G WoutersCostas Koumenis
Apr 2, 2005·Nature Reviews. Molecular Cell Biology·Martin Holcik, Nahum Sonenberg
Dec 1, 2005·Molecular Cancer Research : MCR·Douglas E FeldmanAlbert C Koong
Apr 8, 2006·RNA·Andrew G BertGregory J Goodall
Jul 25, 2006·Cancer Biology & Therapy·Twan van den BeuckenBradly G Wouters
Aug 8, 2006·Seminars in Oncology·Sarah J WelshGarth Powis
Nov 30, 2006·Neoplasia : an International Journal for Oncology Research·Nabendu PoreAmit Maity

❮ Previous
Next ❯

Citations

Jan 18, 2011·Cancer Immunology, Immunotherapy : CII·Katrin SingerAndreas Mackensen
Nov 15, 2011·Archives of Pharmacal Research·Kyeong Lee, Hwan Mook Kim
Aug 28, 2009·Expert Reviews in Molecular Medicine·Evon PoonMargaret Ashcroft
Nov 10, 2009·The Journal of Biological Chemistry·Victoria Moreno-ManzanoJose M Sánchez-Puelles
Jun 6, 2009·Antioxidants & Redox Signaling·Georg T Wondrak
Jul 22, 2011·Molecular Biology of the Cell·Sandrine ChamboredonNadia Cherradi
Dec 20, 2012·Molecular and Cellular Biology·Kai SunPhilipp E Scherer
Jul 16, 2010·Journal of Oncology·J E BohonowychJ S Isaacs
Oct 1, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mei Yee KohGarth Powis
Aug 31, 2011·Genome Medicine·Elena FavaroFrancesca M Buffa
Jun 13, 2009·Future Oncology·Emma S RennelDavid O Bates
Jan 5, 2011·Frontiers in Bioscience (Landmark Edition)·Yuhua ZhaoMing Tan
May 2, 2013·Cancer Research·Taly R Spivak-KroizmanGarth Powis
Oct 11, 2011·Cellular and Molecular Life Sciences : CMLS·Francisco Javier Rodríguez-Jiménez, Victoria Moreno-Manzano
Sep 18, 2009·Journal of Cancer Research and Clinical Oncology·Lei HuangDing Ma
Aug 16, 2014·Cancers·Theerawut ChanmeeNaoki Itano
Dec 19, 2015·Expert Opinion on Biological Therapy·Kevin Rouault-PierreDominique Bonnet
Jan 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Shailesh AgarwalBenjamin Levi
Jul 25, 2015·Journal of Cellular Biochemistry·Shuyang Chen, Nianli Sang
Jan 11, 2014·British Journal of Haematology·Yoko Tabe, Marina Konopleva
Apr 20, 2012·Expert Opinion on Therapeutic Targets·Dylan T Jones, Adrian L Harris
Sep 26, 2015·Oncoimmunology·Jihui Hao
Apr 30, 2015·Current Hematologic Malignancy Reports·Yoko Tabe, Marina Konopleva
Aug 9, 2016·Cancer Immunology, Immunotherapy : CII·Nasim KheshtchinJamshid Hadjati
Jul 28, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Marina KonoplevaMichael Andreeff
Mar 15, 2012·Seminars in Cancer Biology·Eva GottfriedAndreas Mackensen
Aug 11, 2010·Journal of the American Chemical Society·Hyun Seung BanHiroyuki Nakamura
Feb 14, 2013·ACS Medicinal Chemistry Letters·Hidemitsu MinegishiHiroyuki Nakamura
Sep 24, 2008·Trends in Biochemical Sciences·Mei Yee KohGarth Powis
Feb 23, 2010·Molecular Aspects of Medicine·Maximilian J Waldner, Markus F Neurath
Mar 14, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vera L Silva, Wafa' T Al-Jamal
Aug 2, 2011·Translational Oncology·Bryan T OronskyJan Scicinski
Apr 25, 2012·Nature Reviews. Clinical Oncology·Annamaria Rapisarda, Giovanni Melillo
Jun 5, 2018·Journal of Asian Natural Products Research·Xiao-Yu LiuPing Xie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.